Submit Deal

SYNTHON HOLDING

Summary

Synthon operates as a holding company. The Company, through its subsidiaries, provides pharmaceutical products. Synthon offers its products in the active substances, tablets, capsules, powders, and drops forms.

Deals Overview

Total Deals2

Valued Deals1

Total Value£ 1.66 B

Avg. Deal Size£ 1.66 B

Market Context

Subsidiaries

SYNTHON INTERNATIONAL

2 transactions

Senior Management

Edwin de Rooij
CEO
Jacques Lemmens
Founder

Sort

02 Jul 2019|Netherlands|Pharmaceuticals

Target: SYNTHON INTERNATIONAL

Bidder: BC PARTNERS

11 Service Providers

8 Bidder | 3 Vendor

17 Dealmakers

10 Bidder | 7 Vendor

n/a

Value

16 Dec 2024|Netherlands|Pharmaceuticals

Target: SYNTHON INTERNATIONAL

Bidder: GOLDMAN SACHS ASSET MANAGEMENT

18 Service Providers

4 Target | 9 Bidder | 5 Vendor

88 Dealmakers

2 Target | 28 Bidder | 58 Vendor

£ 1.66 B

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy